Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Structure Therapeutics Inc. - American Depositary Shares
(NQ:
GPCR
)
28.65
+2.26 (+8.56%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 27, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
704,886
Open
26.74
Bid (Size)
27.50 (1)
Ask (Size)
28.70 (2)
Prev. Close
26.39
Today's Range
26.62 - 28.82
52wk Range
13.22 - 42.57
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
This Under-the-Radar Healthcare Stock Could Soar in 2026
September 12, 2025
We should know a lot more by year-end.
Via
The Motley Fool
Structure Therapeutics to Participate in Two Upcoming Healthcare Investor Conferences
September 02, 2025
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Performance
YTD
+1.6%
+1.6%
1 Month
+13.2%
+13.2%
3 Month
+56.8%
+56.8%
6 Month
+21.3%
+21.3%
1 Year
-23.5%
-23.5%
More News
Read More
Profusa Inc (NASDAQ: PFSA) Establishes a distributor partner in Spain for Lumee Oxygen platform
August 18, 2025
Via
AB Newswire
Eli Lilly Stock Marks Worst Day In 25 Years As Weight-Loss Pill Data Disappoints: Analysts Divided But Retail Bets On Rebound
August 07, 2025
Via
Stocktwits
Eli Lilly Shares Tumble as Oral Weight-Loss Hope Falls Short of Lofty Expectations
August 07, 2025
Via
MarketMinute
Topics
Economy
Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors
August 07, 2025
Via
Benzinga
Lilly Skids On A Shocking Obesity Setback. Novo, Viking, Structure Surge.
August 07, 2025
Via
Investor's Business Daily
Structure Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights
August 06, 2025
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Structure Therapeutics Announces Two Late-Breaking Poster Presentations at the American Diabetes Association 85th Scientific Sessions Including New Preclinical Data for Oral Small Molecule Amylin Agonist, ACCG-2671
June 20, 2025
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
May 29, 2025
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Structure Therapeutics Reports First Quarter 2025 Financial Results and Recent Highlights
May 08, 2025
From
Structure Therapeutics Inc.
Via
GlobeNewswire
There are notable gap-ups and gap-downs in today's session.
April 17, 2025
Via
Chartmill
uniQure, Hertz Global, Eli Lilly And Other Big Stocks Moving Higher On Thursday
April 17, 2025
Via
Benzinga
Wall Street Sees Pfizer's Weight-Loss Pill Exit As A Win For 2 Smaller Biotech Firms: Retail Turns Bullish
April 15, 2025
Via
Stocktwits
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today
April 14, 2025
Via
The Motley Fool
What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday?
April 14, 2025
Via
Benzinga
The State of Weight Loss Drugs
March 10, 2025
Via
The Motley Fool
AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.
March 03, 2025
Via
Investor's Business Daily
Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights
February 27, 2025
From
Structure Therapeutics Inc.
Via
GlobeNewswire
Why Structure Therapeutics Stock Was Stumbling This Week
February 14, 2025
Via
The Motley Fool
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
January 30, 2025
From
Structure Therapeutics Inc.
Via
GlobeNewswire
AI Pharma: 2 Paths to AI-Powered Drug Investment
January 28, 2025
Via
MarketBeat
Topics
Artificial Intelligence
Biotech Stocks Prepare For Action In 2025. Weight-Loss Drugs, AI And Trump 2.0 Are The Catalysts.
January 09, 2025
Via
Investor's Business Daily
Topics
Artificial Intelligence
Government
Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst
January 06, 2025
Via
Benzinga
Merck Joins The Weight-Loss Race, Inking $2.01 Billion Deal To Take On Eli Lilly, Pfizer, Roche
December 18, 2024
Via
Investor's Business Daily
Frequently Asked Questions
Is Structure Therapeutics Inc. - American Depositary Shares publicly traded?
Yes, Structure Therapeutics Inc. - American Depositary Shares is publicly traded.
What exchange does Structure Therapeutics Inc. - American Depositary Shares trade on?
Structure Therapeutics Inc. - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Structure Therapeutics Inc. - American Depositary Shares?
The ticker symbol for Structure Therapeutics Inc. - American Depositary Shares is GPCR on the Nasdaq Stock Market
What is the current price of Structure Therapeutics Inc. - American Depositary Shares?
The current price of Structure Therapeutics Inc. - American Depositary Shares is 28.65
When was Structure Therapeutics Inc. - American Depositary Shares last traded?
The last trade of Structure Therapeutics Inc. - American Depositary Shares was at 10/27/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.